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ActivationAtaxin-1 is a polyglutamine protein of unknown function that is encoded by the ATXN1 gene in humans.
To gain insight into the function of ataxin-1, we sought to identify proteins that interact with ataxin-1
through yeast two-hybrid screening. In this study, transcriptional corepressor CtBP2 was identiﬁed as a
protein that interacted with ataxin-1. CtBP2 and ataxin-1 colocalized in the nucleus of mammalian cells.
Since the E-cadherin promoter is a target of CtBP-mediated repression, the relationship between ataxin-1
and the E-cadherin promoter was investigated. Chromatin immunoprecipitation assays showed that CtBP2
and ataxin-1 were recruited to the E-cadherin promoter in mammalian cells. Luciferase assays using E-
cadherin promoter reporter constructs revealed that the luciferase activity was enhanced as the level of
ataxin-1 protein expression increased. CtBP2 overexpression decreased E-cadherin expression, but
expression of ataxin-1 inversely increased the mRNA and protein levels of endogenous E-cadherin.
Interestingly, siRNA experiments showed that the transcriptional activation of ataxin-1 was associated
with the presence of CtBP2. This study demonstrates that ataxin-1 occupies the promoter region of E-
cadherin in vivo and that ataxin-1 activates the promoter in a CtBP2-mediated transcriptional regulation
manner.+82 2 927 9028.
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Ataxin-1 is a foci-forming polyglutamine protein of unknown
function, whose mutant form causes spinocerebellar ataxia type 1
(SCA1), an autosomal-dominant neurodegenerative disorder caused
by the expansion of the polyglutamine tract within ataxin-1 [1]. It was
reported that ataxin-1 interacts with several transcriptional co-
regulators, including polyQ-binding protein (PQBP1) [2], leucine-
rich acidic nuclear protein (LANP) [3,4], silencing mediator of
retinoid/thyroid hormone receptors (SMRT) [5], and Sp1 [6]. These
ﬁndings support the idea that ataxin-1 is related to the regulation of
gene expression in the nucleus. To gain further insight into the
function of ataxin-1 as a transcriptional regulator, we sought to
identify proteins that interact with ataxin-1, particularly those that
are involved in transcriptional regulation. C-terminal binding protein
2 (CtBP2), a transcriptional corepressor, was identiﬁed as a protein
interacting with ataxin-1 by a yeast two-hybrid screening.
Members of the C-terminal binding protein (CtBP) family function as
transcriptional corepressors. CtBP was originally identiﬁed based on its
ability to bind the C-terminus of the E1A oncoprotein [7]. It hassubsequently been found in complexes with several known DNA-
binding transcription factors that participate in a wide variety of
developmental and adult biological pathways and processes, including
Wnt and BMP/TGFβ signaling [8–10], GATA factor activity, cell–cell
adhesion, myogenesis, and vascularization [11,12]. CtBP proteins
mediate their transcriptional function through interaction with various
DNA-binding repressors with PLDLS-like motifs and chromatin-modi-
fying enzymes, such as class 1 histone deacetylases (HDAC) without
such motifs. Although the detailed molecular function of CtBP recruited
to DNA by transcriptional factors is unknown, it is quite clear that CtBP
acts as a transcriptional corepressor. Recent work through a combina-
tionof gene trappingandgene targeting in embryonic stemcells showed
that Ctbp1 andCtbp2are necessary for the regulation of geneexpression
inmultiple developmental programs duringmouse embryogenesis [13].
In addition, CtBPs promote epithelial–mesenchymal transition and
mediate repression of several tumor suppressor genes. Previous studies
demonstrated that CtBPs are able to inhibit E-cadherin gene expression
by targeting to the promoter via several repressors such as ZEB, and
recruiting chromatin remodeling complexes [14–16].
As described above, the CtBP family proteins are important
molecules as modulators of several essential cellular processes.
Interactions with speciﬁc modulators in the CtBP transcriptional
regulatory complex may alter the CtBP-mediated gene regulation
function, and especially abnormal interactionsmay cause diseases due
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investigatewhether the presence of ataxin-1 interactingwith CtBP2 has
effects on the CtBP2-mediated repression of the E-cadherin gene as one
of target genes repressed by CtBP2. The evidence linking ataxin-1 to the
regulation of CtBP2-mediated transcription was examined.
2. Materials and methods
2.1. Plasmid constructs
2.1.1. Ataxin-1 constructs
Human full-length ataxin-1 constructs, pcDNAI amp/ataxin-1
(30Q), and pcDNAI amp/ataxin-1(82Q) were generously provided
by Dr. H.T. Orr (Institute of Human Genetics, University of Minnesota).
Full-length and various deleted versions of ataxin-1 cDNAs were
polymerase chain reaction (PCR) ampliﬁed from pcDNAI amp/ataxin-
1 using Pfu polymerase (Stratagene). The PCR-ampliﬁed products
were cloned into EcoRI and XhoI sites of pLexA (Clontech) or
pcDNA3.1 HisC (Invitrogen), and EcoRI and XbaI sites of pCMV-3x
FLAG (Sigma).
2.1.2. CtBP2 constructs
Human full-length CtBP2 constructs, pGAD10/CtBP2, were gener-
ously provided by Dr. A.P. Otte (E. C. Slater Institute, BioCentrum
Amsterdam, University of Amsterdam). The PCR-ampliﬁed full-length
or truncated CtBP2 cDNA was cloned into either pcDNA3.1 HisC or
pCMV-3x FLAG.
2.1.3. Reporter constructs
The full-length E-cadherin promoter reporter construct, including
the region extending from 427 bases upstream to 53 bases
downstream of the E-cadherin transcriptional initiation site, and the
truncated promoter constructs were kind gifts from Dr. Stephen P.
Sugrue (Department of Anatomy and Cell Biology, University of
Florida College of Medicine). This full-length cloned region included
all of the putative regulatory elements of the E-cadherin promoter,
including two palindromic elements (E-boxes), CAAT box, and CpG
island [18].
2.1.4. Small interference RNA
Small interference RNA oligomers for a knock-down of endoge-
nous CtBP2 were purchased from Dharmacon. The purchased
siGENOME SMARTpool (M-008962-03) contains a mixture of four
SMART selection-designed siRNAs targeting the CtBP2 gene. The
control siRNA oligomers, non-targeting negative siRNA control pools
(D-001206-13) were purchased from Dharmacon.
2.2. Yeast two-hybrid screening
The yeast expression construct pLexA-DBD/ataxin-1(82Q) was
sequentially cotransformed with a human fetal brain Matchmaker
two-hybrid library (Clontech) into yeast strain EGY48 (Clontech). For
the library selection, approximately 1×107 independent transfor-
mants were plated on selective medium lacking the amino acids
leucine, histidine, and tryptophan but containing 5-bromo-4-chloro-
3-indolyl-beta-D-galactoside (X-gal). Five days later, Leu+- and LacZ
+-positive colonies were picked. The selected positive clones were
sequenced by an ABI sequencer, and the sequence of each clone was
analyzed using the NCBI BLASTN program.
2.3. Yeast quantitative β-galactosidase assays
Transformants selected on histidine- and tryptophan-deﬁcient
plates were cultured in histidine- and tryptophan-deﬁcient liquid
medium supplemented with glucose for 24 h. For the induction of the
Lex-DBD fusion protein and B42AD fusion protein, the liquid culturewas transferred to induction medium supplemented with galactose
and rafﬁnose instead of glucose. At 5 h after induction, the optical
density of each culture was measured at 600 nm, and the quantitative
β-galactosidase assay was performed with o-nitrophenyl-β-D-galac-
topyranoside (ONPG). β-Galactosidase activity was measured at
420 nm using a multi-well plate reader (Bio-Rad). Each assay was
performed in triplicate with separate colonies in two independent
experiments.
2.4. Cell culture and transfection
HeLa and HEK293T cells were maintained in DMEM supplemented
with 10% fetal bovine serum, streptomycin (100 μg/ml), and penicillin
(100 U/ml). MCF-7 cells were cultured in RPMI supplemented with
10% fetal bovine serum, streptomycin (100 μg/ml), and penicillin
(100 U/ml). Transfections were performed with Lipofectamine (Invi-
trogen) or polyethyleneimine (Sigma-Aldrich) as previously de-
scribed [19]. Mixtures combined at the DNA to reagent ratio of 1:3
were incubated in serum-free OPTI-MEM for 15 min. After incubation,
DNA–reagent complexes were applied to the cells. Hela cells were
used to study intranuclear IFA, and MCF cells expressing a lot of E-
cadherin were employed for Western blot experiments.
2.5. Co-immunoprecipitation experiments
HEK293T cells were transiently transfected with Xpress-tagged
CtBP2 (pcDNA3.1 HisC/CtBP2) and either FLAG-tagged ataxin-1
(pcDNAI amp/ataxin-1) or empty vectors. At 48 h after the transfection,
the cells were harvested and co-immunoprecipitation experiments
were performed as previously described [20]. The immunoprecipitates
were subjected to 10% sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS-PAGE) and the separated proteins were
transferred onto nitrocellulose. The blots were probed with either
anti-FLAG (Sigma) or anti-Xpress antibody (Invitrogen), and detected
with the ECL system (Pharmacia).
2.6. Immunoﬂuorescence experiments
HeLa cells split on a coverslip were transiently transfected with
each construct as indicated in Fig. 2. After 24 h post-transfection, the
cells were ﬁxed with 3.7% formaldehyde in phosphate buffered saline
(PBS) for 15 min, and then permeabilized with 1% Triton X-100 in PBS
for 5 min. The permeabilized cells were blockedwith 2% bovine serum
albumin (BSA) in PBS for 1 h at 4 °C, and then incubated for 1 h at
room temperature with mouse anti-FLAG antibody (1:500). The cells
were rinsed with PBS three times, and incubated with tetramethylr-
hodamine isothiocyanate (TRITC, Sigma-Aldrich)-conjugated anti-
mouse IgG antibodies (red) for 1 h. Then, the cells were stained with
4′,6′-diamidino-2-phenylindole dihydrochloride (DAPI, Sigma-
Aldrich) to observe the nucleus. Finally, the coverslips were rinsed
three times with PBS and mounted on glass slides with FluoroGuard™
Antifade Reagent (Bio-Rad). Fluorescence imageswere obtained using
a ﬂuorescence microscope (OLYMPUS) and processed with Adobe
Photoshop.
2.7. Chromatin immunoprecipitation (ChIP)
A ChIP assay was performed as previously described [21].MCF-7 cells
were transfected with 4 μg DNAs of FLAG-tagged-ataxin-1(30Q), FLAG-
taggedCtBP2or empty vectors. At 48 h after transfection, cellswere cross-
linked in 1% formaldehyde and the cross-linking reaction was quenched
by adding 0.2 M glycine. Pellets collected by centrifugation were washed
twicewith ice-coldTris buffered saline, and then three timeswithMC lysis
buffer (10 mM Tris–Cl [pH 7.5], 10 mM NaCl, 3 mMMgCl2, and 0.5% NP-
40), which disrupted the cells and generated a nuclear pellet. The nuclear
pellet was resuspended with MNase buffer (10 mM Tris–Cl [pH 7.5],
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methanesulphonylﬂuoride (PMSF)) and then 2 mM PMSF, 1× protease
inhibitors, 1% SDS, and 200 mM NaCl were added in the order indicated
and mixed well. The resuspended pellet was sheared by sonication to
reduce the DNA fragment size to approximately 500 bp. After removing
cellular debris, chromatin samples were diluted (1:4) by adding FA lysis
buffer (50 mM HEPES [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% Triton X-
100, 0.1% sodiumdeoxycholate, and0.1%SDS) containing2mMPMSFand
1× protease inhibitors, and precleared with protein G-Sepharose beads
(GE Healthcare Bio-Sciences). Ten percent of the precleared chromatin
was taken as an input, and the remaining supernatant was immunopre-
cipitated with anti-FLAG antibody at 4 °C for 4 h. Immunoprecipitated
samples were additionally incubated at 4 °C for 2 h with the addition of
protein G-sepharose. DNA and proteins non-speciﬁcally associated with
the protein G-Sepharose were removed bywashing the beads twice with
FA lysis buffer/0.15 M NaCl, once with FA lysis buffer/0.5 M NaCl, ChIP
washing buffer (10 mM Tris–Cl [pH 8.0], 0.25 M LiCl, 1 mM EDTA, 0.5%
NP-40, and0.5% sodiumdeoxycholate), andﬁnallywith TEbuffer (10 mM
Tris–Cl [pH 8.0], and 1 mM EDTA). The beads were then resuspended in
ChIP elution buffer (50 mMTris–Cl [pH7.5], 10 mM EDTA, and 1% SDS) at
65 °C for 10 min. The eluted protein–DNA complexes were incubated at
42 °C for 2 h in the presence of 2 mg/ml proteinase K to digest the protein,
followed by incubation at 65 °C overnight to reverse formaldehyde cross-
linking. The DNA was phenol-extracted and ethanol-precipitated.
Precipitated DNA was PCR-ampliﬁed with CDH1 (E-cadherin) primers
as previously described [22,23] to detect the human E-cadherin promoter
region. The sequences of the CDH1 primers were (forward) 5′-
ACTCCAGGCTAGAGGGTCAC-3′ and (reverse) 5′-CCGCAAGCTCA-
CAGGTGCTTTGCAGTTCC-3′. The human TK gene was used as a negative
control. The TK gene sequences were (forward) 5′-TCCCGGATTCCTCC-
CACGAG-3′ and (reverse) 5′-TGCGCCTCCGGGAAGTTCAC-3′ [19,24]. The
PCR cycling conditions were as follows: 95 °C for 5 min; then 35 cycles of
94 °C for 20 s, 56 °C for 20 s, and 72 °C for 20 s; followed by 72 °C for
5 min. The ampliﬁed DNA was separated on a 1.5% agarose gel and
visualized with ethidium bromide.
2.8. Sequential chromatin immunoprecipitation (SeqChIP)
SeqChIP assay was performed as described previously [25,26].
MCF-7 cells were cotransfected with FLAG-tagged-CtBP2 and Xpress-
tagged-ataxin-1(30Q). Twenty-four hours later, transfected cells were
treated according to conventional ChIP procedures by ﬁrst performing
IP with anti-FLAG antibody. Protein–DNA complexes obtained by the
ﬁrst IP were subjected to an additional IP with anti-Xpress antibody,
anti-CtBP2 antibody (C-16, Santa Cruz Biotechnology) or IgG anti-
mouse in SeqChIP. First, the precipitated complexes were eluted via a
10 min incubation with 100 μl of ChIP elution buffer (10 mM Tris–Cl
[pH 7.5], 10 mM EDTA, and 1% SDS) at 65 °C. At this point, 10 μl as the
ﬁrst IP sample was removed from the sample for subsequent analysis
of the ﬁrst immunoprecipitation elutes (90 μl). For SeqChIP, the
elutants were incubated in the presence of 5 mg/ml BSA, 25 μg/ml
phage λ DNA, 50 μg/ml yeast tRNA, an appropriate amount of each
antibody, and 50 μl of protein G-Sepharose in a total volume of 1 ml FA
lysis buffer (150 mM NaCl, without SDS) to make the second
immunoprecipitation similar to the initial one. The washes, elution,
and crosslink reversal following the second IP were carried out as
described above.
2.9. Quantitative real-time PCR (qPCR)
qPCR of the DNA samples described above was used to assess the
extent of co-occupancy. Each PCR reaction was performed in triplicate
in a total volume of 20 μl in each well, containing one-tenth of each IP
sample or the ﬁrst IP sample as a template DNA, 1 μM CDH1 primers
and 2× SYBR Green Master mix (Takara Bio). qPCR was performed on
a Light Cycler 480 (Roche Applied Science). The PCR conditions wereas follows: initial denaturation at 95 °C for 5 min, followed by 35–37
cycles of 95 °C for 10 s, 59 °C for 10 s, and 72 °C for 20 s. Thresholds
cycles (Ct) were determined as recommended by the manufacturer's
software. The ampliﬁed DNA was separated on a 1.5% agarose gel and
visualized with ethidium bromide.
2.10. Luciferase reporter assay
HEK293T cells were cotransfected with 0.2 μg of pGL3–E-cadherin
reporter gene constructs, 0.1 μg of pSV–β-galactosidase control vector
(Promega), and the indicated amount of a given type of DNA per dish
using the polyethylenimine precipitation method. The pSV–β-galac-
tosidase construct was used as an internal control for transfection
efﬁciency. The amount of DNA in each transfection reaction was
equalized to control for non-speciﬁc effects on the expression of
luciferase using an empty expression vector. After transfection, the
cells were incubated for 24 h and assayed for luciferase expression
using Promega's Luciferase Assay System according to the manufac-
turer's instructions. The luciferase reporter activity was measured
with the Luminoskan Ascent (Thermo Labsystems). Each experiment
was performed more than at least two independent experiments in
triplicate. Statistical analysis was performed using a t-test.
2.11. Reverse transcription-PCR (RT-PCR) analysis
MCF-7 cells were transfected with DNA as indicated in Fig. 4B.
After 36 h, total RNA was isolated from transfected MCF-7 cells using
TRIzol reagent (Invitrogen). RT-PCR reactions were carried out using
the SuperScript III First-Strand Synthesis System (Invitrogen) accord-
ing to the manufacturer's instructions. cDNA was synthesized from
1 μg of total RNA using the oligo(dT)20 primer. The cDNA obtained in
the synthesis reaction was ampliﬁed using PCR, which was carried out
at an annealing temperature of 60 °C for 30 cycles for E-cadherin and
at an annealing temperature of 57 °C for 25 cycles for β-actin. The
primer sequences used in the PCR experiments were described
previously [27]. The target sequences for E-cadherin were (forward)
5′-TTCCTCCCAATACATCTCCCTTCACAG-3′ and (reverse) 5′-CGAA-
GAAACAGCAAGAGCAGCAGAATC-3′ [28]. The target sequences for β-
actin were (forward) 5′-CCAACTGGGACGACATGGAG-3′ and (reverse)
5′-GCACAGCTTCTCCTTAATGTC-3′.
3. Results
3.1. Identiﬁcation of human CtBP2 as a protein interacting with ataxin-1
To identify proteins that interact with ataxin-1, we performed a yeast
two-hybrid screening using full-length mutant ataxin-1(82Q) as bait
(Fig. 1A). Yeast expressing ataxin-1 was sequentially transformedwith a
human fetal brain cDNA library. The partial cDNA encoding the
C-terminal region (amino acids 203–445) of the human C-terminal
bindingprotein 2 (CtBP2)was isolated from independent positive clones.
To conﬁrm the interaction between ataxin-1 and the CtBP2 C-terminal
region (CtBP2203–445), we performed β-galactosidase assays using the
yeast two-hybrid system. Strong β-galactosidase activity was observed in
yeast cells expressing LexA-ataxin-1 and pB42AD-CtBP2203–445, whereas
weak activity was shown in cells containing LexA-ataxin-1(82Q) and
pB42AD, or LexA-BD and pB42AD-CtBP2203–445 (Fig. 1B), indicating that a
speciﬁc interaction exists betweenCtBP2203–445 and ataxin-1, and that the
polyglutamine tract of ataxin-1 does not modulate the interaction
between ataxin-1 and CtBP2203–445.
To deﬁne the protein region responsible for the interaction
between ataxin-1 and CtBP2, deleted versions of ataxin-1 were
expressed as LexA-BD fusion proteins in yeast. As shown in Fig. 1C,
LacZ reporter genes were strongly activated in cells co-expressing
pB42AD-CtBP2 and LexA-ataxin-1N-terminus (a.a. 1–196). However,
β-galactosidase activities were weak in cells expressing the protein
Fig. 1. Identiﬁcation of hCtBP2 as a protein that interacts with ataxin-1(82Q). (A) Schematic representation of ataxin-1 and CtBP2. Full-length humanmutant ataxin-1(82Q) fused to
LexA-DBD was used as bait in a yeast two-hybrid screening. Clone number 38, represented as CtBP2203–445, corresponded to the C-terminal region of hCtBP2. (B) CtBP2203–445
speciﬁcally interacts with ataxin-1. β-Galactosidase activity in liquid culture was quantiﬁed after yeasts were cotransformed with the indicated constructs. LexA-ataxin-1(82Q) and
pB42AD, or LexA-BD and pB42AD-CtBP2203–445, and LexA-p53 and pB42AD-CtBP2203–445 were used as negative and positive controls, respectively. (C) Schematic representation of
various ataxin-1 deletion mutants fused to LexA-DBD. β-Galactosidase activity was quantiﬁed after yeasts were cotransformed with the indicated constructs and full-length
pB42AD-CtBP21–445. Yeast cells expressing LexA-atrophin-1 and pB42AD-CtBP2 were served as a negative control. Mean values and standard deviations from two independent
experiments performed in triplicate are shown.
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ataxin-1C-terminus (a.a. 537–816) and pB42AD-CtBP2. These results
suggest that the N-terminal (a.a. 1–196) region of ataxin-1 is essential
for the protein–protein interaction. In control experiments, co-
expression of pB42AD-CtBP2 and LexA-atrophin-1 (the DRPLA gene
product) C-terminus did not show β-galactosidase activity, while
activation did occur with pB42AD-TAg and LexA-p53 performed as the
positive control.
Co-immunoprecipitation experiments were carried out in mam-
malian cells to verify the interaction between CtBP2 and ataxin-1.
Constructs containing Xpress-tagged CtBP2 and either FLAG-tagged
ataxin-1(30Q or 82Q), or empty vectors were cotransfected into
HEK293T cells. After 48 h, total cell extracts were prepared and
immunoprecipitated with anti-FLAG antibodies. Fig. 2A shows that
CtBP2 proteins were co-immunoprecipitated with ataxin-1(30Q) or
ataxin-1(82Q) (Fig. 2A, lanes 1 and 2) but not with pcDNA1 empty
vector (Fig. 2A, lane 3). In addition, PLDLS-binding motifs of CtBP2
did not appear to be necessarily required for interaction with
ataxin-1 (Supplementary Fig. 1). These results are indicative of an
interaction between CtBP2 and ataxin-1 in vivo, and indicate that
the length of the polyglutamine tract does not affect the interaction
between the two molecules. Additional reciprocal co-immunopre-
cipitation assays using anti-Xpress antibodies also conﬁrmed the
speciﬁc interaction between ataxin-1 and CtBP2 in mammalian cells
(data not shown).3.2. Ataxin-1 colocalizes with CtBP2 in the nucleus
CtBP has been known to be diffusely distributed both in the nucleus
and cytoplasm [7,29–31]. On the other hand, it was reported that
ataxin-1 proteins formnuclear inclusions (NIs) inmammalian cells. To
examine the distribution of CtBP2 in the presence of ataxin-1 in
mammalian cells, HeLa cells were cotransfected with the expression
plasmid of pEGFP-ataxin-1(30Q) or ataxin-1(82Q), and FLAG-tagged
CtBP2, and immunoﬂuorescence experiments were performed using
anti-FLAGantibodies. In cotransfectedHeLa cells, CtBP2were observed
in the same loci with both ataxin-1(30Q) and ataxin-1(82Q) (Fig. 2B),
indicating that CtBP2 and ataxin-1 colocalize in the nucleus.
Additionally, to investigate the distribution of endogenous CtBP in
mammalian cells, HeLa cells expressing exogenous ataxin-1 was
analyzed using immunoﬂuorescence confocal microscopy (Supple-
mentary Fig. 2). Exogenous ataxin-1 was localized in nuclear
inclusions (NIs) and endogenous CtBP was shown to be diffusely
distributed throughout the cell. In HeLa cells expressing exogenous
ataxin-1, however, CtBP was redistributed into NIs of ataxin-1.
3.3. Both ataxin-1 and CtBP2 occupy the endogenous E-cadherin promoter
in vivo
Several transcriptional factors, such as TBP and CBP, contain
glutamine tracts. Polyglutamine disease proteins, including androgen
Fig. 2. Ataxin-1 interacts and colocalizes with CtBP2 in the nucleus. (A) HEK293T cells were transiently cotransfected with FLAG-tagged ataxin-1 and Xpress-tagged CtBP2. After 48 h,
total cell extracts were prepared and immunoprecipitated with anti-FLAG antibodies. The resulting immunoprecipitates were Western blotted and analyzed with the anti-Xpress
antibody to detect CtBP2 (top). This blot was stripped and probed with anti-FLAG antibody to detect immunoprecipitated FLAG-ataxin-1 (middle). Each whole cell extract was
resolved by SDS-PAGE and immunoblotted with anti-Xpress antibody to detect exogenous CtBP2 (bottom). (B) HeLa cells were cotransfected with expression plasmids of FLAG-
tagged CtBP2 and either pEGFP control or pEGFP-ataxin-1. At 24 h post-transfection, cells were immunolabeledwith anti-FLAG antibody and TRITC-conjugated anti-mouse IgG (red).
Fluorescence images were obtained using a ﬂuorescence microscope (OLYMPUS). Merged signals are shown in yellow.
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tional factors. The interaction between ataxin-1 and CtBP2 strongly
suggests that ataxin-1 functions as a transcriptional regulator within a
CtBP corepressor complex. CtBP proteins exist as corepressor com-
plexes consisting of a variety of transcriptional regulators [32]. We
tried to identify a target gene(s) regulated by ataxin-1 in terms of
CtBP2-mediated transcriptional regulation. It was previously reported
that the transcriptional regulation of E-cadherinmight involve several
repressor complexes, such as the SIN3 repressor complex and CtBP
corepressor complex [33]. Therefore, we used ChIP assays to examine
whether CtBP2 and ataxin-1 are recruited to the E-cadherin promoter.
MCF-7 cells were transfected with FLAG-tagged CtBP2 or ataxin-1.
Formaldehyde cross-linked chromatin extracts from transfected MCF-
7 cells were immunoprecipitated with anti-FLAG antibodies, and the
presence of CDH1 (E-cadherin) promoter sequences was detected by
PCR with speciﬁc primers. Anti-IgG antibody IP and TK promoter
primer ampliﬁcation were used as non-speciﬁc controls and negative
controls, respectively. TheWestern blot analysis shown in Fig. 3A was
carried out to evaluate the overexpression of each protein for the ChIP
assay. The CDH1 promoter region was enriched when either CtBP2 or
ataxin-1 was precipitated with anti-FLAG antibody, while the TK
promoter sequences were not (Fig. 3B). These results show that both
CtBP2 and ataxin-1 occupy the endogenous E-cadherin promoter in
vivo.
Furthermore, sequential ChIP (SeqChIP) was used to qualitatively
address whether two proteins can simultaneously co-occupy a stretch
of E-cadherin promoter sequences in vivo. MCF-7 cells were
cotransfected with FLAG-tagged CtBP2 and Xpress-tagged ataxin-1
constructs. First, IP with anti-FLAG antibody against CtBP2 proteins
was performed with DNAs eluted from formaldehyde cross-linkedchromatin extracts prepared from MCF-7 cells expressing the two
proteins, followed by a second IP with anti-Xpress, anti-CtBP2
antibodies, or anti-mouse IgG. DNAs eluted through the SeqChIP
process were quantiﬁed by real-time PCR. E-cadherin promoter
occupancy was determined by the amount of PCR product yielded
after triplicate ampliﬁcations. PCR products ampliﬁed by real-time
PCR were normalized to products acquired by the non-speciﬁc anti-
IgG IP.Western blot analysis (Fig. 3C) indicated that CtBP2 and ataxin-
1 proteins were sufﬁciently overexpressed for the SeqChIP assays to
be performed. Fig. 3D shows that two proteins might simultaneously
co-occupy a stretch of E-cadherin promoter, but it also indicates that
the two proteins associate with different populations of the E-
cadherin promoter sequence and ataxin-1 is a part of transcriptional
complexes occupying speciﬁc sites on the E-cadherin promoter.
Ataxin-1 proteins appear to partially occupy the E-cadherin promoter
relative to CtBP2 proteins. These results suggest that CtBP2 and
ataxin-1 are co-recruited on the E-cadherin promoter to form
transcriptional complexes.3.4. Overexpression of ataxin-1 enhances E-cadherin expression at the
protein and mRNA levels in MCF-7 cells
To determine whether ataxin-1 can affect the expression of
endogenous E-cadherin,Western blot analysis was performed to detect
alterations in the E-cadherin protein levels after transfection with
Xpress-tagged ataxin-1 or CtBP2. For the Western blot analysis,
duplicate experiments were performed. The diagram in Fig. 4A (lower
panel) shows the relativeamountsof E-cadherinproteinsnormalizedby
β-actin proteins using Multi-Gauge (FUJIFILM) software. Interestingly,
Fig. 3. Both ataxin-1 and CtBP2 occupy the endogenous E-cadherin promoter in vivo. (A) FLAG-tagged CtBP2 and -ataxin-1(30Q) were transfected into MCF-7 cells, respectively.
Western blot analysis was performed to evaluate each protein overexpression for the ChIP assay. (B) Chromatin extracts eluted fromMCF-7 cells expressing CtBP2 and ataxin-1 were
immunoprecipitated using anti-FLAG antibody, and PCR-ampliﬁed with speciﬁc primers, such as CDH1 (E-cadherin) or TK promoter primer. Chromatin DNA extract from empty
vector transfected cells, anti-IgG IP, and TK promoter primer ampliﬁcation were used as non-speciﬁc or ‘non-target’ controls to detect the E-cadherin promoter sequence. (C) MCF-7
cells were cotransfected with FLAG-tagged CtBP2 and Xpress-tagged ataxin-1(30Q) constructs. Western blot analysis was performed to detect overexpressed-proteins for the
SeqChIP assay. The IgG control lane in Fig. 2D could be a control of Fig. 2C and D. (D) IP with anti-FLAG antibody against CtBP2 proteins was performed with DNAs eluted from
formaldehyde cross-linked chromatin extracts prepared from MCF-7 cells co-expressing the two proteins, followed by a second IP with anti-Xpress, anti-CtBP2 antibodies, or anti-
mouse IgG. DNAs eluted through the SeqChIP process were quantiﬁed by real-time PCR. E-cadherin promoter occupancy was determined by the amount of PCR product yielded after
triplicate ampliﬁcations. The ampliﬁed PCR products were normalized to products yielded by an anti-IgG IP. The SeqChIP products ampliﬁed by real-time PCR were separated on a
1.5% agarose gel and visualized with ethidium bromide (lower panel).
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cadherin proteins.
Then, real-time PCRwas carried out to quantify the mRNA levels of
E-cadherin. MCF-7 cells were transfected with FLAG-tagged CtBP2
and/or Xpress-tagged ataxin-1(30Q) as indicated in Fig. 4B. Total RNAFig. 4. Ataxin-1 increases the levels of E-cadherin proteins and mRNAs in MCF-7 cells. (A)
plasmids and harvested 24 h later. Western blot analysis was performed in duplicate exp
proteins normalized by β-actin proteins usingMulti-Gauge (FUJIFILM) software. (B) Transfec
later. Total RNA was isolated from the lysed cells and cDNAs were synthesized using RT-P
ampliﬁed with E-cadherin or β-actin primers by real-time PCR. PCR products ampliﬁed by the
reaction was performed in triplicate. Two independent experiments were performed and rwas isolated from the lysed cells and cDNAs were synthesized using
RT-PCR. The cDNAs were ampliﬁed with E-cadherin or β-actin
primers by real-time PCR. PCR products ampliﬁed by the E-cadherin
primer were normalized to those ampliﬁed by the β-actin primer. PCR
was performed in triplicate. E-cadherin mRNA level was increased inMCF-7 cells were transiently transfected with Xpress-tagged ataxin-1(30Q) or CtBP2
eriments, and the histogram (lower panel) shows the relative amounts of E-cadherin
tedMCF-7 cells with each expression vector for ataxin-1 and CtBP2were harvested 36 h
CR employing oligo(dT)20 primer. The cDNAs obtained in the synthesis reaction were
E-cadherin primer were normalized to those ampliﬁed by the β-actin primer. Each PCR
epresentative one was shown. The error bars indicate standard deviations.
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overexpressed ataxin-1 affects the transcriptional regulation of the
E-cadherin gene in MCF-7 cells.
3.5. Ataxin-1 activates the E-cadherin gene promoter in a CtBP2-dependent
manner
The relationship between ataxin-1 and CtBP2 in transcriptional
regulation of E-cadherin gene was investigated. First, luciferase assays
were performed using either Xpress-tagged CtBP2 or ataxin-1, and
full-length E-cadherin promoter reporter constructs (−427 +53)
[18]. Overexpression of the CtBP2 protein enhanced the repression
activity of the E-cadherin promoter in a dose-dependent manner,
whereas overexpression of ataxin-1 increased the activity of the
E-cadherin promoter in a dose-dependent manner (Fig. 5A and B).
To further understand the functional mechanism of interaction
between ataxin-1 and CtBP2 in E-cadherin gene regulation, we
investigated the activity of reporter genes mediated by ataxin-1 in the
presence or absence of the CtBP2 proteins. HEK293T cells were
transfected with CtBP2 siRNA oligomers as much as amounts
indicated in Fig. 5C. As predicted, depletion of endogenous CtBP2
increased the luciferase activity of E-cadherin promoter. It was
examined whether ataxin-1 overexpression could affect the tran-
scriptional activity of the E-cadherin promoter in a knock-down
condition of endogenous CtBP2. Xpress-tagged ataxin-1 as indicated
in Fig. 5D was transiently cotransfected with either 20 pM of CtBP2
siRNA or control siRNA oligomers into HEK293T cells. The over-
expressed cells were harvested and assayed 24 h later. When
endogenous CtBP2 proteins were depleted by siRNA oligomers
targeting the CtBP2 gene (Fig. 5D, gray bars), overexpression of
ataxin-1 slightly enhanced the luciferase activity of the E-cadherinFig. 5. Ataxin-1 activates the E-cadherin gene promoter in a CtBP2-dependent manner. (A
reporter gene (−427 +53). HEK293T cells were transfected with two different concentrat
promoter reporter gene, pSV–β-galactosidase constructs. (C) CtBP2 siRNA oligomers wer
HEK293T cells. (D) HEK293T cells were transiently cotransfected with Xpress-tagged ata
oligomers (20 pM). Transfected cells were harvested and assayed 24 h later. Luciferase repor
independent experiments in triplicate. Statistical analysis was performed using a t-test.promoter and overexpression of an increased amount of ataxin-1
consistently maintained its activity level. However, in cells expressing
endogenous CtBP2 proteins (Fig. 5D, black bars), ataxin-1 increased its
activity in a dose-dependent manner. These results suggest that
ataxin-1 might effectively regulate the promoter of the E-cadherin
gene in the presence of CtBP2, indicating a functional linkage between
ataxin-1 and CtBP2 on the regulation of E-cadherin promoter. Taken
together, it is assumed that ataxin-1 proteinsmight be recruited to the
CtBP2 transcriptional regulatory complex, resulting in activating the
E-cadherin promoter in a CtBP2-dependent manner.
3.6. Full-length E-cadherin promoter is essential for the recruitment of
ataxin-1 and the transcriptional activation by ataxin-1
CtBP2 proteins are recruited to promoter by sequence-speciﬁc
DNA-binding transcription factors such as ZEB (zinc-ﬁnger E-box
binding homeobox) and snail, either through direct interaction or
indirectly through bridging protein. These transcription factors block
E-cadherin expression by binding to speciﬁc E-box in the E-cadherin
promoter [28,34]. Therefore, we performed the luciferase assay using
several truncated reporter constructs to examine whether recruit-
ment of ataxin-1 on the E-cadherin promoter depends on CtBP2
proteins. The E-cadherin promoter contains several important cis-
regulatory elements, including an upstream E-box 1 (CAGGTG;−78),
conserved CCAAT box (−65), CpG island (−52 −32), and down-
stream E-box 2 (CACCTG;−28) [18,35]. These cis-regulatory elements
are often binding sites of one or more trans-acting factors.
Cotransfection was performed with full-length ataxin-1(30Q) and
each truncated E-cadherin promoter construct as shown in Fig. 6. The
full-length cloned region, including all of the putative regulatory
elements of the E-cadherin promoter, was the most responsive toand B) Luciferase assays were performed using the full-length E-cadherin promoter
ions of Xpress-tagged ataxin-1(30Q) or CtBP2 as indicated, along with the E-cadherin
e transfected in three different concentrations to assess silencing effects of CtBP2 in
xin-1(30Q) at two different concentrations and either CtBP2 siRNA or control siRNA
ter activity was normalized with β-galactosidase. Each experiment was performed three
AB
Fig. 6. Full-length E-cadherin promoter is essential for the recruitment of ataxin-1 and
the transcriptional activation by ataxin-1. (A) Schematic representation of truncated E-
cadherin promoter constructs. (B) Luciferase assay was carried out using full-length or
several truncated E-cadherin promoter reporter constructs. HEK293T cells were
transfected with each reporter construct and Xpress-tagged ataxin-1(30Q) or empty
vectors. The bars show the luciferase activity of each reporter gene in response to
ataxin-1 or empty vectors. Each experiment was performed two independent
experiments in triplicate.
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tions of the human E-cadherin promoter activity were observed in
cells transfected with truncated E-cadherin promoter constructs.
Especially, the E-box 1 deletion mutant drastically reduced the
luciferase activity of the reporter gene, indicating that this box
might be critical for the recruitment of the ataxin-1 on the E-cadherin
promoter and thus ataxin-1-induced activation.
4. Discussion
Ataxin-1 is predominantly located in the nuclei of neurons [1], and
is known to interact with several transcriptional co-regulators, such as
PQBP1, LANP, SMRT, and Sp1. Mutant ataxin-1 enhances the
repression of transcription in the presence of PQBP1 [2]. However,
ataxin-1 relieves the transcriptional repression induced by the LANP-
E4F complex by competing with E4F for LANP [4]. Thus, ataxin-1 has
an important role in transcriptional regulation. The function of ataxin-
1 might be changeable between repressor and activator depending on
speciﬁc cellular contexts. Our study reveals that ataxin-1 is capable of
up-regulating the expression of E-cadherin by reducing the effect of
CtBP2-mediated repression on the E-cadherin gene.
We wondered about the mechanism by which ataxin-1 affects the
function of CtBP2. ChIP assays in Fig. 3 indicate that the ataxin-1 and
CtBP2 proteins co-occupy the E-cadherin promoter. Furthermore, the
results of the siRNA experiments summarized in Fig. 5 imply that the
transcriptional activation of ataxin-1 is associated with the presence
of CtBP2. On the basis of these results, a hypothesis of the mechanism
by which ataxin-1 activates the E-cadherin promoter is proposed. As
shown in Fig. 7, overexpression of CtBP2 decreases the E-cadherin
promoter activity, and overexpression of ataxin-1 in the presence of
endogenous CtBP2 inversely increases the promoter activity. Ataxin-1
proteins in the presence of endogenous CtBP2 might be recruited into
the CtBP2-mediated transcriptional complexes on the E-cadherinpromoter and could affect the regulation of E-cadherin promoter.
However, the depletion of CtBP2 with CtBP2 siRNA might block the
access of ataxin-1 to the E-cadherin promoter region as drawn in the
bottom panel of Fig. 7. However, the promoter activity in the bottom
panelmight be higher than that in the top panel because the depletion
of CtBP2 by CtBP2 siRNA oligomers can relieve the basal repression
activities on the E-cadherin promoter, and alternatively a small
quantity of CtBP2 that is not depleted, can recruit ataxin-1 proteins
into the transcriptional complexes, resulting in increasing the
promoter activity. Conclusively, this study identiﬁed the E-cadherin
promoter as a novel molecular target that can be regulated by ataxin-
1, suggesting that ataxin-1 might enhance E-cadherin expression by
relieving transcriptional repression by CtBP2. Alternatively, CtBP2
could be recruited to ataxin-1 NIs, whichwould decrease the available
pool of CtBP2, resulting in the increase of E-cadherin expression.
Further study is required to understand the mechanism by which
ataxin-1 enhances E-cadherin expression.
There are an increasing number of reports suggesting that
polyglutamine diseases may result from the transcriptional dysre-
gulation caused by mutant proteins with expanded polyglutamine
tracts in speciﬁc neuronal populations. Similarly, the connection of
ataxin-1 with the regulation of a gene expression provides a
fascinating hypothesis regarding the onset mechanism of SCA1.
Since the gene expression process is a very complicated phenom-
enon controlled by the coordinated action of transcriptional
regulators, transcriptional dysregulation mediated by mutant
ataxin-1 might be an important feature of SCA1 pathogenesis by
altering general functions of a variety of regulatory nuclear proteins
through the disruption of interactions or creation of new ones with
other regulatory proteins. Indeed, Fernandez-Funez et al. reported
that transcriptional regulation cofactors including Sin3A, Rpd3, and
dCtBP are one group of genes that modify ataxin-1-induced
neurodegeneration [17].
Changes in gene expression during the early stage of development
have been observed in SCA1 transgenic mice [36]. At the same time,
the fact that CtBP2 is presently expressed during the early stages of
development and is necessary for the regulation of gene expression in
multiple developmental programs suggests that CtBP2 may mediate
the transcriptional dysregulation in SCA1. In addition, E-cadherin
genes that are known to be repressed by CtBP are transiently
expressed in restricted regions of mouse embryonic brain, and the
expression is in part associated with local pattern formation of brain
tissues [37,38]. Therefore, we have focused on E-cadherin. The
abnormal alteration of E-cadherin expression level by mutant
ataxin-1 and CtBP2 might affect cerebellar Purkinje cells, severe and
frequent pathology sites of SCA1.
In this study, a relief of CtBP2-mediated repression with mutant
ataxin-1(82Q) (data not shown) as well as wild-type ataxin-1(30Q)
was found. However, overexpressed ataxin-1(82Q) proteins in-
creased more the level of E-cadherin mRNA and the luciferase
activity of E-cadherin promoter than ataxin-1(30Q) proteins. We
could not detect functional differences regarding the E-cadherin
gene regulation between wild-type and mutant ataxin-1. The result
might not be surprising, given that overexpressed wild-type proteins
in cell lines can induce similar effects as mutant proteins.
Nevertheless, the studies of the expression proﬁles of speciﬁc target
genes that are regulated by ataxin-1 might contribute to the
elucidation of SCA1 pathology and the development of new and
potent therapeutic strategies. Although the transcriptional molecular
mechanism of the interaction between ataxin-1 and CtBP2 in the
pathogenesis of SCA1 remains to be investigated, we propose that
interference of CtBP-mediated transcriptional repression due to the
binding of ataxin-1 to CtBP2 might be involved in the SCA1
pathogenic mechanisms.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2011.01.035.
Fig. 7. Ataxin-1 activates the promoter in a CtBP2-mediated transcriptional regulation manner. The overexpression of the CtBP2 repressor reduces the E-cadherin promoter activity
(top). The addition of ataxin-1 in the presence of endogenous CtBP2 enhances the promoter activity by directly interacting with CtBP2 (middle). The depletion of CtBP2 with siRNA
CtBP2 blocks the access of the ataxin-1 to the promoter (bottom).
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